Complications of cva
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Complications of Cerebrovascular Accidents (CVA)
Introduction to Cerebrovascular Accidents (CVA)
Cerebrovascular accidents (CVA), commonly known as strokes, are significant medical events that can lead to severe complications and increased mortality. Understanding the complications associated with CVA is crucial for improving patient outcomes and developing effective prevention strategies.
Complications in Sickle Cell Disease Patients
CVA is a major complication in patients with sickle cell disease (SCD). The highest rates of CVA prevalence and incidence are observed in patients with sickle cell anemia (SS). Infarctive strokes are more common in children and older patients, while hemorrhagic strokes peak in patients aged 20 to 29 years. Hemorrhagic strokes have a high mortality rate of 26% within two weeks, whereas infarctive strokes do not result in immediate deaths. Risk factors for infarctive strokes include prior transient ischemic attacks, low hemoglobin levels, recent acute chest syndrome, and high systolic blood pressure. Hemorrhagic strokes are associated with low hemoglobin and high leukocyte counts.
CVA in Pediatric Patients with Sickle Cell Anemia
In pediatric patients with sickle cell anemia, CVA is a serious complication. Factors such as the absence of α-gene deletions and specific βS haplotypes (e.g., Ben/CAR) increase the risk of CVA. Children with four or more α-genes and certain βS haplotypes are at higher risk for CVA.
CVA After Coronary Artery Bypass Grafting (CABG)
CVA is a deleterious complication following coronary artery bypass grafting (CABG). Risk factors include advanced age, low left ventricular ejection fraction, unstable angina, diabetes mellitus, chronic renal failure, redo surgery, peripheral vascular disease, and previous CVA. Perioperative factors such as longer myocardial ischemia and cardiopulmonary bypass times also contribute to the risk. Prevention strategies should focus on preoperative risk assessment and tailored clinical approaches.
CVA in Chronic Renal Failure Patients
Patients with chronic renal failure (CRF) have a higher incidence of atherosclerotic CVA compared to the general population. Risk factors include cigarette smoking, high systolic blood pressure, low HDL cholesterol, and high levels of LDL cholesterol, triglycerides, apoB, Lp(a), fibrinogen, and homocysteine. These factors are potentially modifiable, suggesting that early intervention could reduce the risk of CVA in CRF patients.
CVA After Transcatheter Aortic Valve Implantation (TAVI)
CVA is a serious complication following transcatheter aortic valve implantation (TAVI). Most CVA events occur within the first day post-procedure and are associated with repeated device implantation attempts, chronic pulmonary disease, and low body mass index. CVA significantly increases the risk of mortality within 30 days of the procedure.
CVA in Pediatric Ventricular Assist Device (VAD) Patients
CVA is a common complication in pediatric patients with ventricular assist devices (VADs). Risk factors include ascites, higher patient profile groups, and implants in small volume centers. Despite improvements in recent years, CVA remains significantly associated with increased mortality in these patients.
CVA in Patients with Diabetes
Patients with diabetes mellitus (DM) hospitalized for CVA have an increased risk of in-hospital death and complications compared to non-diabetic patients. High plasma glucose levels at admission are associated with a higher risk of death. These findings highlight the need for early diagnosis and management of diabetes in high-risk individuals to reduce the burden of adverse outcomes.
Conclusion
Cerebrovascular accidents (CVA) are associated with various complications across different patient populations, including those with sickle cell disease, chronic renal failure, post-CABG, post-TAVI, and pediatric VAD patients. Identifying and managing risk factors is crucial for preventing CVA and improving patient outcomes. Early intervention and tailored clinical strategies are essential in high-risk groups to mitigate the impact of CVA.
Sources and full results
Most relevant research papers on this topic